RICO Lawsuit Claims Fraudulent Ranbaxy Audits Prolonged Generic Exclusivity

Drug Industry Daily
A A
A group of indirect purchasers filed a RICO lawsuit against Indian drugmaker Ranbaxy, claiming the company cost them millions of dollars through a criminal enterprise.

To View This Article:

Login

Subscribe To Drug Industry Daily